English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Mar 11, 2026

FDA partially pauses PepGen's phase 2 trial for myotonic dystrophy
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

FDA official seeks hire amid controversy over antidepressant warnings
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

Alnylam partners with Tenaya Therapeutics on genetic heart disease research
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

Analysts say psychedelics unlikely to dominate depression treatment market
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

UniQure weighs next steps after FDA requests new phase 3 trial for Huntington's gene therapy
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

Targeted mRNA restores fertility in genetically infertile male mice
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

Study links impaired tanycyte function to tau buildup in Alzheimer’s disease
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

Wuhan University study links chronic sleep loss to impaired social memory via oxytocin circuits

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes